Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

57
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

131
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
131
Inflammation01:38

Inflammation

52.5K
Overview
52.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein(a) as a Risk Factor for Myocardial Infarction, Cardiovascular, and All-Cause Mortality in Patients with Type 2 Diabetes Mellitus.

Diagnostics (Basel, Switzerland)·2026
Same author

Multidimensional Profiles of Recovery: Using Correspondence Analysis to Visualize Physiotherapy Outcomes in Patients with Chronic Low Back Pain.

Journal of clinical medicine·2026
Same author

Machine Learning in Primary Health Care: The Research Landscape.

Healthcare (Basel, Switzerland)·2025
Same author

Trusting AI made decisions in healthcare by making them explainable.

Science progress·2024
Same author

Trends in Physiotherapy of Chronic Low Back Pain Research: Knowledge Synthesis Based on Bibliometric Analysis.

Healthcare (Basel, Switzerland)·2024
Same author

Left Atrial Volume Index Predicts Atrial Fibrillation Recurrence after Catheter Ablation Only in Obese Patients-Brief Report.

Diagnostics (Basel, Switzerland)·2024
Same journal

Correction: Luca et al. Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative Synthesis. <i>Diagnostics</i> 2026, <i>16</i>, 1224.

Diagnostics (Basel, Switzerland)·2026
Same journal

Association Between Systemic Inflammatory Response Biomarkers and Disease Activity in Systemic Lupus Erythematosus: A Multi-Center Retrospective Study.

Diagnostics (Basel, Switzerland)·2026
Same journal

Vertebrogenic Low Back Pain and Basivertebral Nerve Ablation: A Review of Mechanisms, Imaging-Driven Selection, and Clinical Outcomes.

Diagnostics (Basel, Switzerland)·2026
Same journal

Multivalvular Carcinoid Heart Disease: The Role of Echocardiography in Diagnosis and Selection for Heterotopic Bicaval Valve Implantation.

Diagnostics (Basel, Switzerland)·2026
Same journal

Data-Efficient and Explainable Multimodal Survival Prediction in NSCLC Using Deep Image Embeddings, Clinical Variables, and Gradient-Boosted Trees.

Diagnostics (Basel, Switzerland)·2026
Same journal

Anomalous Left Coronary Artery from the Pulmonary Artery: Cinematic Volume Rendering Technique for Enhanced Anatomic Visualization.

Diagnostics (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.2K

Lipoprotein(a) as a Risk Factor for Recurrent Acute Myocardial Infarction and Mortality: Insights from Routine

David Šuran1,2, Vojko Kanič1,2, Peter Kokol2,3

  • 1Clinical Department of Cardiology and Angiology, University Medical Centre Maribor, Ljubljanska ulica 5, 2000 Maribor, Slovenia.

Diagnostics (Basel, Switzerland)
|December 17, 2024
PubMed
Summary
This summary is machine-generated.

Elevated Lipoprotein(a) [Lp(a)] levels increase recurrent heart attack risk in women over 65. This study found no significant link between Lp(a) and mortality in acute myocardial infarction patients.

Keywords:
acute myocardial infarctionall-cause mortalitycardiovascular mortalitylipoprotein(a)risk factorwomen

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

27.8K

Related Experiment Videos

Last Updated: Jun 5, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.2K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

27.8K

Area of Science:

  • Cardiology
  • Biochemistry
  • Epidemiology

Background:

  • Lipoprotein(a) [Lp(a)] is a known risk factor for atherosclerotic cardiovascular disease.
  • Limited evidence exists on Lp(a)'s association with recurrent cardiovascular events after an initial event.

Purpose of the Study:

  • To investigate the association between Lp(a) levels and recurrent acute myocardial infarction (AMI), cardiovascular mortality, and all-cause mortality in patients hospitalized for AMI.
  • To explore potential sex and age-specific differences in these associations.

Main Methods:

  • Retrospective analysis of routine clinical data from 2248 patients hospitalized for AMI between 2000 and 2022.
  • Patients stratified into three Lp(a) level groups: ≤50 mg/dL, 51-90 mg/dL, and >90 mg/dL.
  • Multivariable-adjusted Cox regression analysis to assess outcomes.

Main Results:

  • Elevated Lp(a) (>90 mg/dL) was associated with a 1.51-fold increased risk of recurrent AMI (p=0.013) compared to levels ≤50 mg/dL.
  • No significant associations were found between Lp(a) levels and cardiovascular or all-cause mortality.
  • A significant association between Lp(a) and recurrent AMI was observed only in women aged >65 years, with adjusted HRs of 2.34 (51-90 mg/dL) and 3.94 (>90 mg/dL).

Conclusions:

  • Lipoprotein(a) is associated with a significantly higher risk of recurrent AMI specifically in women over 65 years with Lp(a) levels >50 mg/dL.
  • No significant associations were found between Lp(a) and cardiovascular or all-cause mortality in the overall study population.